EVEROLIMUS-19-ENE OPEN RING

UNII:	QAQ4Q483BA
Type:	INGREDIENT SUBSTANCE
Formula:	C₅₃H₈₃NO₁₄
Preferred Substance Name:	EVEROLIMUS-19-ENE OPEN RING
InChIKey:	PRSJHEVLVQFMHJ-FRLQEACCSA-N
GSRS Full Record:	QAQ4Q483BA i

1062122-63-7
(S)-1-{2-[(2R,3R,6S)-2-Hydroxy-6-{(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl}-3-methyltetrahydro-2H-pyran-2-yl]-2-oxoacetyl}piperidine-2-carboxylic acid
2-Piperidinecarboxylic acid, 1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]acetyl]-, (2S)-
Everolimus EP Impurity B (Acid)
Everolimus-19-ene open ring

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

EVEROLIMUS-19-ENE OPEN RING

Synonyms and Mappings

Resources